Former smoking is a risk factor for chronic kidney disease after lung transplantation

American Journal of Transplantation

Volumn 11, Issue 11, 2011, Pages 2490-2498

  Hellemons, M E ^a   Agarwal, P K ^a   Van Der Bij, W ^a   Verschuuren, E A M ^a   Postmus, D ^a   Erasmus, M E ^a   Navis, G J ^a   Bakker, S J L ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Chronic kidney disease; Lung transplantation; Pack years; Smoking

Indexed keywords

CYCLOSPORIN; IOTALAMIC ACID I 125; TACROLIMUS;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE III; CHRONIC KIDNEY DISEASE IV; CONFIDENCE INTERVAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HAZARD RATIO; HUMAN; INCIDENCE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ADULT; CYCLOSPORINE; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SMOKING; SMOKING CESSATION; TACROLIMUS;

EID: 84857189200     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03701.x     Document Type: Article

References (37)

1. Canales M, Youssef P, Spong R, et al. Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation. Am J Transplant 2006; 6: 2157-2163. (Pubitemid 44199550)
2. Bloom RD, Doyle AM. Kidney disease after heart and lung transplantation. Am J Transplant 2006; 6: 671-679. (Pubitemid 43345004)
3. Wilkinson AH, Cohen DJ. Renal failure in the recipients of nonrenal solid organ transplants. J Am Soc Nephrol 1999; 10: 1136-1144. (Pubitemid 29203102)
4. Goldstein DJ, Zuech N, Sehgal V, Weinberg AD, Drusin R, Cohen D. Cyclosporine-associated end-stage nephropathy after cardiac transplantation: Incidence and progression. Transplantation 1997; 63: 664-668. (Pubitemid 27132197)
5. Christie JD, Edwards LB, Aurora P, et al. Registry of the international society for heart and lung transplantation: Twenty-fifth official adult lung and heart/lung transplantation report-2008. J Heart Lung Transplant 2008; 27: 957-969.
6. Christie JD, Edwards LB, Aurora P, et al. The registry of the international society for heart and lung transplantation: Twenty-sixth official adult lung and heart-lung transplantation report-2009. J Heart Lung Transplant 2009; 28: 1031-1049.
7. Sung RS, Althoen M, Howell TA, Ojo AO, Merion RM. Excess risk of renal allograft loss associated with cigarette smoking. Transplantation 2001; 71: 1752-1757. (Pubitemid 32622486)
8. Kasiske BL, Klinger D. Cigarette smoking in renal transplant recipients. J Am Soc Nephrol 2000; 11: 753-759. (Pubitemid 30171885)
9. van der Heide F, Dijkstra G, Porte RJ, Kleibeuker JH, Haagsma EB. Smoking behavior in liver transplant recipients. Liver Transpl 2009; 15: 648-655.
10. Auerbach O, Hammond EC, Garfinkel L. Smoking in relation to atherosclerosis of the coronary arteries. N Engl J Med 1965; 273: 775-779.
11. Hammond EC, Horn D. Smoking and death rates; Report on fortyfour months of follow-up of 187,783 men. I. Total mortality. J Am Med Assoc 1958; 166: 1159-1172.
12. Sherman CB. The health consequences of cigarette smoking. Pulmonary diseases. Med Clin North Am 1992; 76: 355-375.
13. Pinto-Sietsma SJ, Mulder J, Janssen WM, Hillege HL, De Zeeuw D, De Jong PE. Smoking is related to albuminuria and abnormal renal function in nondiabetic persons. Ann Intern Med 2000; 133: 585-591.
14. Orth SR, Ritz E, Schrier RW. The renal risks of smoking. Kidney Int 1997; 51: 1669-1677. (Pubitemid 27252734)
15. Vos R, De Vusser K, Schaevers V, et al. Smoking resumption after lung transplantation: A sobering truth. Eur Respir J 2010; 35: 1411-1413.
16. Evon DM, Burker EJ, Sedway JA, Cicale R, Davis K, Egan T. Tobacco and alcohol use in lung transplant candidates and recipients. Clin Transplant 2005; 19: 207-214. (Pubitemid 40424891)
17. Apperloo AJ, De Zeeuw D, Donker AJ, De Jong PE. Precision of glomerular filtration rate determinations for long-term slope calculations is improved by simultaneous infusion of 125I-iothalamate and 131I-hippuran. J Am Soc Nephrol 1996; 7: 567-572. (Pubitemid 126427122)
18. Visser FW, Muntinga JH, Dierckx RA, Navis G. Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate. Clin J Am Soc Nephrol 2008; 3: 1308-1315.
19. Donker AJ, Van der Hem GK, Sluiter WJ, Beekhuis H. A radioisotope method for simultaneous determination of the glomerular filtration rate and the effective renal plasma flow. Neth J Med 1977; 20: 97-103. (Pubitemid 8129523)
20. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150: 604-612.
21. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 1989; 5: 303-311, discussion 312-313.
22. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Am J Kidney Dis 2002; 39(Suppl 1): S1-266.
23. Broekroelofs J, Stegeman CA, Navis GJ, et al. Creatinine-based estimation of rate of long term renal function loss in lung transplant recipients. Which method is preferable? J Heart Lung Transplant 2000; 19: 256-262. (Pubitemid 30122388)
24. Bakker NA, Verschuuren EA, Erasmus ME, et al. Epstein-Barr virus-DNA load monitoring late after lung transplantation: A surrogate marker of the degree of immunosuppression and a safe guide to reduce immunosuppression. Transplantation 2007; 83: 433-438. (Pubitemid 46667847)
25. Scrucca L, Santucci A, Aversa F. Competing risk analysis using R: An easy guide for clinicians. Bone Marrow Transplant 2007; 40: 381-387. (Pubitemid 47202424)
26. Gjertson DW, Dabrowska DM, Cui X, Cecka JM. Four causes of cadaveric kidney transplant failure: A competing risk analysis. Am J Transplant 2002; 2: 84-93. (Pubitemid 36306811)
27. Rockhill B, Newman B,Weinberg C. Use andmisuse of population attributable fractions. Am J Public Health 1998; 88: 15-19.
28. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: Competing risks and multi-state models. Stat Med 2007; 26: 2389-2430. (Pubitemid 46730255)
29. Kunst H, Thompson D, Hodson M. Hypertension as a marker for later development of end-stage renal failure after lung and heartlung transplantation: A cohort study. J Heart Lung Transplant 2004; 23: 1182-1188. (Pubitemid 39346235)
30. Ojo AO, Held PJ, Port FK, et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940. (Pubitemid 37064766)
31. Lhotta K, Rumpelt HJ, Konig P, Mayer G, Kronenberg F. Cigarette smoking and vascular pathology in renal biopsies. Kidney Int 2002; 61: 648-654. (Pubitemid 34102608)
32. Leunissen KM, Bosman FT, Nieman FH, et al. Amplification of the nephrotoxic effect of cyclosporine by preexistent chronic histological lesions in the kidney. Transplantation 1989; 48: 590-593. (Pubitemid 19267475)
33. Launay JM, Del Pino M, Chironi G, et al. Smoking induces longlasting effects through a monoamine-oxidase epigenetic regulation. PLoS One 2009; 4: E7959.
34. Rendu F, Peoc'h K, Berlin I, Thomas D, Launay JM. Smoking related diseases: The central role of monoamine oxidase. Int J Environ Res Public Health 2011; 8: 136-147.
35. Novello AC. Surgeon general's report on the health benefits of smoking cessation. Public Health Rep 1990; 105: 545-548.
36. Dew MA, Dimartini AF, De Vito Dabbs A, et al. Adherence to the medical regimen during the first two years after lung transplantation. Transplantation 2008; 85: 193-202. (Pubitemid 351156849)
37. Aigner C, Winkler G, Jaksch P, et al. Extended donor criteria for lung transplantation-a clinical reality. EurJ Cardiothorac Surg 2005; 27: 757-761. (Pubitemid 40585666)